ClinicalTrials.Veeva

Menu

Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding

S

Sichuan University

Status

Unknown

Conditions

Esophageal and Gastric Varices

Treatments

Procedure: bi-weekly Endoscopic Variceal Ligation (EVL)
Procedure: monthly Endoscopic Variceal Ligation (EVL)

Study type

Interventional

Funder types

Other

Identifiers

NCT02719119
monthly versus bi-weekly EVL

Details and patient eligibility

About

Many physicians suggest repeating EVL every 1-2 weeks until esophageal varices are obliterated to prevent variceal rebleeding, however, the evidences supporting the efficacy of EVL intervals of 1-2 weeks are insufficient.This randomized controlled study was conducted in order to compare the long-term results of EVL when performed at two different results from monthly and bi-weekly treatments.

Full description

Endoscopic variceal ligation (EVL) is a safe and simple procedure now being used on a widening scale. A lot of patients who undergo endoscopic treatment for esophageal varices eventually require additional treatment for recurrent varices. Many physicians suggest repeating EVL every 1-2 weeks until esophageal varices are obliterated to prevent variceal rebleeding, however, the evidences supporting the efficacy of EVL intervals of 1-2 weeks are insufficient.This randomized controlled study was conducted in order to compare the long-term results of EVL when performed at two different results from monthly and bi-weekly treatments.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. acute or recent bleeding from esophageal varices;
  2. portal hypertension caused by cirrhosis;
  3. age between 18 and 80 yr.

Exclusion criteria

  1. history of endoscopic, pharmacological, interventional or surgical treatment of esophageal varices;
  2. presence of liver failure with a serum total bilirubin concentration greater than 3 mg/dL;
  3. presence of hepatocellular carcinoma or other malignancy;
  4. an association with a cerebral vascular accident, uremia, acute coronary syndrome, or other severe illness;
  5. history of gastric variceal bleeding;
  6. encephalopathy of stage II or worse;
  7. failure to control initial variceal bleeding;
  8. death within 48 h of admission;
  9. refusal to participate in the trial.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

monthly EVL
Experimental group
Description:
Elective band ligation was applied after premedication with hyoscine-N-butylbromide (20 mg intramuscularly). A multiband ligator and video endoscopes were utilized. Ligation was initiated at or slightly below the bleeding point. During each treatment session, each varix was ligated with one or two elastic bands. Variceal obliteration success was when all varices disappeared or residual varices were too small to be ligated further. Once esophageal varices were obliterated, surveillance endoscopy was performed every 3 months for 1 year and then every 6 months to check for recurrent varices. Patients in this group will underwent endoscopic variceal ligation monthly.
Treatment:
Procedure: monthly Endoscopic Variceal Ligation (EVL)
bi-weekly EVL
Experimental group
Description:
Elective band ligation was applied after premedication with hyoscine-N-butylbromide (20 mg intramuscularly). A multiband ligator and video endoscopes were utilized. Ligation was initiated at or slightly below the bleeding point. During each treatment session, each varix was ligated with one or two elastic bands. Variceal obliteration success was when all varices disappeared or residual varices were too small to be ligated further. Once esophageal varices were obliterated, surveillance endoscopy was performed every 3 months for 1 year and then every 6 months to check for recurrent varices. Patients in this group will underwent endoscopic variceal ligation bi-weekly.
Treatment:
Procedure: bi-weekly Endoscopic Variceal Ligation (EVL)

Trial contacts and locations

1

Loading...

Central trial contact

XUEFENG LUO, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems